🇺🇸 Enteric Coated Aspirin in United States

252 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Myocardial Infarction — 79 reports (31.35%)
  2. Coronary Artery Disease — 46 reports (18.25%)
  3. Cardiac Failure Congestive — 39 reports (15.48%)
  4. Acute Myocardial Infarction — 28 reports (11.11%)
  5. Cerebrovascular Accident — 14 reports (5.56%)
  6. Fall — 10 reports (3.97%)
  7. Arthrofibrosis — 9 reports (3.57%)
  8. Atrial Fibrillation — 9 reports (3.57%)
  9. Dyspnoea — 9 reports (3.57%)
  10. Nausea — 9 reports (3.57%)

Source database →

Enteric Coated Aspirin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Enteric Coated Aspirin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Enteric Coated Aspirin in United States?

Dartmouth-Hitchcock Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.